APA (7th ed.) Citation

E, Y., A, G., M, K., O, K., E, O., E, S., & G, T. (2026). Donafenib suppresses glioblastoma progression: Potential enhancement of therapeutic response in TMZ-resistant models. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05631-z

Chicago Style (17th ed.) Citation

E, Yazici, Gezen A, Kalay M, Kocak O, Oylumlu E, Simsek E, and Tanriover G. "Donafenib Suppresses Glioblastoma Progression: Potential Enhancement of Therapeutic Response in TMZ-resistant Models." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05631-z.

MLA (9th ed.) Citation

E, Yazici, et al. "Donafenib Suppresses Glioblastoma Progression: Potential Enhancement of Therapeutic Response in TMZ-resistant Models." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05631-z.